therapeutic potential of ides in hemophilia a with inhibitors
Published 1 year ago • 257 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:23
the present and future of hemophilia a treatment
-
2:27
the impact of hemophilia inhibitors on patient outcomes
-
2:40
treatment options for patients with hodgkin lymphoma who have relapsed after three lines of therapy
-
1:09
highlights from isth: gene therapy in hemophilia a & undiagnosed bleeding disorders in pediatrics
-
3:23
new approaches to hemophilia research
-
20:08
hemophilia a - bleeding - most comprehensive explanation - hematology, bleeding, and coagulation
-
2:56
plan to attend isth 2024 in bangkok for the latest science in thrombosis and hemostasis
-
1:17
emerging strategies to support patients with hemophilia a
-
1:12
promising novel agents for hemophilia a/b: gene therapies and extended half-life products
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
4:06
a phase ii trial of intermittent treatment strategies for ndmm to avoid asct
-
0:39
promising therapeutic options emerging in hemophilia
-
1:43
quality of life in patients with hemophilia: the impact of bleeds & the benefits of gene therapy
-
4:57
a potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
-
1:36
unmet needs in hemophilia: guidelines for emicizumab & better therapeutics for hemophilia a
-
1:44
diagnostic yield of a new multigene panel test in patients with suspected cardiac amyloidosis
-
1:06
overview of the diagnostic work-up for hemophilia
-
2:47
safety and tolerability sglt2 inhibitors in the treatment of cardiac amyloidosis
-
0:54
immune response monitoring in patients with hemophilia treated with gene therapy
-
1:05
promising antibodies being explored in hemophilia & a novel diagnostic tool for patients
-
0:44
simoctocog alfa for the treatment of patients with hemophilia a